Nephrology Doctors in Kew Gardens, NY Accepting Medicare

3 Nephrology doctors found. Showing 1 - 3

Dr. Gail Nurit Frumkin, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12320 82nd Ave, Kew Gardens, NY 11415 Phone: 718-830-3333    Fax: 718-830-3722

Dalia Frumkin, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12320 82nd Ave, Kew Gardens, NY 11415 Phone: 718-830-3333    Fax: 718-830-3722

Dr. Michael M Goldman, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12046 Queens Blvd, Kew Gardens, NY 11415 Phone: 718-793-3341    Fax: 718-268-1666

News Archive

EMBL scientists develop Fly Digital Embryo to film development of fruit fly, zebrafish's eyes and brain

The scientists at the European Molecular Biology Laboratory in Heidelberg, Germany, who 'fathered' the Digital Embryo have now given it wings, creating the Fly Digital Embryo. In work published today in Nature Methods, they were able to capture fruit fly development on film, and were the first to clearly record how a zebrafish's eyes and midbrain are formed.

'Achilles' heel' of deadly superbug identified

A deadly superbug that infects an estimated 54,500 Americans a year has a secret weapon, a protein, that allows it to defy antibiotic treatment and immune system attacks.

Scientists identify potential target that could combat allergies of early childhood

A pandemic of ailments called the "allergic march" - the gradual acquisition of overlapping allergic diseases that commonly begins in early childhood - has frustrated both parents and physicians. For the last three decades, an explosion of eczema, food allergies, hay fever, and asthma have afflicted children in the United States, the European Union, and many other countries.

Genentech's Lucentis for treatment of macular edema following RVO receives FDA approval

Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved Lucentis® (ranibizumab injection) for the treatment of macular edema following retinal vein occlusion (RVO). The FDA approved this new indication after a six-month Priority Review.

Single chemotherapy treatment can negatively impact gait and balance, study shows

A single chemotherapy treatment can result in a significant negative impact on walking gait and balance, putting patients at an increasing risk for falls, according to a new study involving breast cancer patients conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

Read more Medical News

› Verified 6 days ago